labetalol and 1,2-dimyristoylphosphatidylethanolamine

labetalol has been researched along with 1,2-dimyristoylphosphatidylethanolamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jemiola-Rzeminska, M; Strzalka, K; Suwalsky, M; Zambrano, P	1

Other Studies

1 other study(ies) available for labetalol and 1,2-dimyristoylphosphatidylethanolamine

Article	Year
α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes. Biochemical and biophysical research communications, 2018, 09-03, Volume: 503, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Calorimetry, Differential Scanning; Dimyristoylphosphatidylcholine; Erythrocyte Membrane; Erythrocytes; Humans; In Vitro Techniques; Labetalol; Liposomes; Membranes, Artificial; Microscopy, Electron, Scanning; Phosphatidylethanolamines; X-Ray Diffraction	2018

Article

Year

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes.

Biochemical and biophysical research communications, 2018, 09-03, Volume: 503, Issue:1

Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Calorimetry, Differential Scanning; Dimyristoylphosphatidylcholine; Erythrocyte Membrane; Erythrocytes; Humans; In Vitro Techniques; Labetalol; Liposomes; Membranes, Artificial; Microscopy, Electron, Scanning; Phosphatidylethanolamines; X-Ray Diffraction

2018